Societies

Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types

Photo taken from Moderna/LinkedIn

Apr 9, 2024, 16:41

Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types

Quoting Moderna on LinkedIn:

“Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types, harnessing the body’s immune system to identify and kill cancer cells.

We believe the adaptability of mRNA technology can be leveraged to create an innovative and diverse portfolio of investigational cancer therapies, including individualized approaches.

Join us at AACR24 in San Diego at booth 441 as we continue to showcase the potential of mRNA technology and the possibility of changing cancer care and improving outcomes for patients.”

Source: Moderna/LinkedIn

AACR24 cancer Cancer research cancer therapies cancer treatment Innovation Medical Advancements Medical Technology mmuno-oncology Moderna mRNA OncoDaily Oncology San Diego

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers